Rchr
J-GLOBAL ID:200901041054969658   Update date: Sep. 05, 2024

Yajima Toshiki

ヤジマ トシキ | Yajima Toshiki
Affiliation and department:
Research field  (2): Respiratory surgery ,  Immunology
Research keywords  (6): 肺癌 ,  転移性肺腫瘍 ,  肺区域切除 ,  胸腔鏡下手術 ,  低侵襲手術 ,  腫瘍免疫
Research theme for competitive and other funds  (15):
  • 2023 - 2026 bFGF徐放ゼラチンシートを用いた新しい気管支断端補強剤の開発
  • 2022 - 2025 Galectin 3阻害剤創薬による難治疾患の病態解明と治療応用を目指した研究
  • 2022 - 2025 がん細胞特異的アミノ酸トランスポーターを標的とした新規複合的がん免疫療法の開発
  • 2022 - 2025 Galectin 3阻害剤創薬による難治疾患の病態解明と治療応用を目指した研究
  • 2022 - 2025 癌細胞ならびに腫瘍免疫寛容の同時制御を目指した新規治療ツール開発
Show all
Papers (170):
  • Chihiro Yoshida, Kyuichi Kadota, Emi Ibuki, Ryou Ishikawa, Reiji Haba, Toshiki Yajima. Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma. Anticancer research. 2024. 44. 3. 1289-1297
  • Chihiro Yoshida, Kyuichi Kadota, Kaede Yamada, Syusuke Fujimoto, Emi Ibuki, Ryou Ishikawa, Reiji Haba, Toshiki Yajima. CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas. Clinical and experimental medicine. 2023. 14. 8. 1260492-5200
  • Ryotaro Ohkuma, Sakiko Miura, Satoshi Muto, Yoshitaka Toyomasu, Yuki Fujimoto, Katsuaki Ieguchi, Nobuyuki Onishi, Takashi Shimizu, Makoto Watanabe, Daisuke Takayanagi, et al. Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors. Frontiers in immunology. 2023. 14. 1260492
  • Syuusuke Fujimoto, Kadota Kyuichi, Yamada Kaede, Yoshida Chihiro, Ibuki Emi, Ishikawa Ryo, Haba Reiji, Yajima Toshiki, Hiroyasu Yokomise. RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor-associated macrophages. Thoracic cancer. 2023. 14. 17. 1581-1588
  • Seshiru Nakazawa, Kimihiro Shimizu, Tomohiro Yazawa, Natsuko Kawatani, Kai Obayashi, Yoichi Ohtaki, Takayuki Kosaka, Toshiki Yajima, Ken Shirabe. Clinicopathological features and surgical outcomes of lobectomy combined with segmentectomy: a cohort study. Journal of thoracic disease. 2023. 15. 3. 1075-1085
more...
MISC (382):
more...
Books (2):
  • バイオ研究マスターシリーズ 免疫学 集中マスター
    羊土社 2005
  • 免疫学 最新イラストレイテッド
    羊土社 2003
Education (2):
  • 1999 - 2002 Gunma University
  • 1991 - 1997 Gunma University Faculty of Medicine
Professional career (1):
  • 条件付 (Gunma University)
Work history (6):
  • 2022/04 - 現在 Faculty of medicine, Kagawa University Department of General Thoracic Surgery
  • 2019/04 - 2022/03 群馬大学大学院先端腫瘍免疫治療学講座 准教授
  • 2018/10 - 2019/03 群馬大学大学院総合外科学講座 講師
  • 2013/04 - 2018/09 群馬大学大学院総合外科学講座 助教
  • 2005/09 - 2008/03 群馬大学総合外科学講座 助教
Show all
Awards (1):
  • 2005/07 - 日本生体防御学会奨励賞 抗原特異的CD8T細胞の活性化誘導細胞死におけるインターロイキン-15の役割
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page